The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment
Halit ÇinarkaGülşah GünlüoğluMustafa CortukSibel YurtMurat KıyıkA Filiz KosarElif TanriverdİMelih Akay ArslanKurşad Nuri BaydiliAysu Sinem KoçSedat AltınErdoğan ÇetinkayaPublished in: Turkish journal of medical sciences (2021)
The use of favipiravir was more effective than LPV/RTV in reducing mortality in hospitalized patients with COVID-19.